Treatment with 60 mg of BEAM-302 Led to Mean Steady-state Total AAT Level of 16.1 µM and All Patients Consistently and Durably Above the 11 µM ...

Beam Therapeutics (NASDAQ:BEAM) executives and clinical collaborators presented updated top-line data from the company’s ...

The Fibrosis-4 (FIB-4) index, computed from age, aspartate aminotrasfertase (AST) and alanine aminotransferase (ALT) levels, and platelet count, was originally developed in 832 pa ...

In the U.S., FDA approval establishes Opdivo in combination with doxorubicin, vinblastine and dacarbazine (AVD) as the first immunotherapy combination approved for adult and pediatric patients 12 ...

FIB-4 index shows limited accuracy for individual MASLD patients. Learn more about its role and challenges in liver fibrosis ...

Researchers have discovered in a new study that among patients with Cushing's syndrome, treatment with GLP-1 drugs led to ...

TG Therapeutics, Inc. (“TG” or “the Company”), (NASDAQ: TGTX), today announced that it has entered into a new five-year, $750 million senior secured credit facility with funds managed by Blue Owl ...

Very rarely will a disease kill a person without giving adequate signs, especially if the person is listening appropriately to the body. Perhaps it is extremely contagious diseases like Ebola that can ...

Katie Thurston, 35, is bravely preparing for her double mastectomy amid stage 4 breast cancer, saying that she’ll be going ...

Immunic (NASDAQ:IMUX) executives outlined what they described as a “transformative” 2026, with pivotal data expected late in ...

CAPE CANAVERAL SPACE FORCE STATION — For those who woke up early on Thursday morning, they got to see SpaceX launch AST SpaceMobile’s five commercial satellites despite the weather not looking ...